Buscar
Mostrando documentos 11-20 de 33
Contingent assessment of the COVID-19 vaccine
The COVID-19 pandemic has not only had a negative impact on people’s health and life behavior, but also
on economies around the world. At the same time, laboratories and institutions are working hard to
obtain a COVID-19 ...
SARS-CoV-2 Vaccine development: Current Status
In the midst of the SARS-CoV-2 pandemic and its attendant morbidity and mortality, safe
and efficacious vaccines are needed that induce protective and long-lived immune responses.
Over 120 vaccine candidates worldwide ...
Vaccination strategies to combat novel corona virus SARS-CoV-2
The 2019-novel coronavirus disease (COVID-19) is caused by SARS-CoV-2 is transmitted from human to human
has recently reported in China. Now COVID-19 has been spread all over the world and declared epidemics by
WHO. It ...
Data mining and analysis of scientific research data records on Covid- 19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic
Background and aims: Covid-19 is a global pandemic that requires a global and integrated response of all
national medical and healthcare systems. Covid-19 exposed the need for timely response and data
sharing on fast ...
Nanomedicine strategies to target coronavirus
With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle east
respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS-CoV-2 in
December 2019, the 21st first century has ...
Prevention and treatment of COVID-19: focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) has drawn the attention of researchers and clinicians from several disciplines and sectors
who are trying to find durable ...
SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
The development of a massively producible vaccine against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential
for stopping the current coronavirus disease (COVID-19) pandemic. ...
Current state of vaccine development and targeted therapies for COVID-19: Impact of basic science discoveries
Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). SARS-CoV-2 is closely related to two other coronaviruses that caused disease
epidemic breakouts in humans in ...
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Background The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by
vaccination. We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine ...